Literature DB >> 1154810

Metabolism of papaverine. III. Effect of phenobarbital, 3-methylcholanthrene and SKF 525-A pre-treated in vivo and in vitro.

F M Belpaire, M G Bogaert.   

Abstract

1. The metabolism of papaverine was studied in vitro using the 9000 g fraction of rat liver. Apparent Km and Vmax values were 1.6 X 10-5 M and 34 nmol/g/min. Three monodemethylated metabolites were found by t.l.c. 2. Pre-treatment of rats with phenobarbital enhanced the activity of papaverine O-demethylase, whereas pre-treatment with 3-methylcholanthrene did not. Pre-treatment with SKF 525-A, or addition of AKF 525-A invitro markedly inhibited the enzyme. 3. Pre-treatment of the rats with phenobarbital enhanced the biliary elimination rate of papaverine metabolites, whereas SKF 525-A pre-treatment slowed this elimination.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1154810     DOI: 10.3109/00498257509056113

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  Studies on liver toxicants. Influence of bromobenzene on hepatic microsomal enzymes in rats.

Authors:  F E Beyhl; D G Mayer
Journal:  Arch Toxicol       Date:  1980-02       Impact factor: 5.153

2.  Qualitative and quantitative determination of drotaverine metabolites in rat bile.

Authors:  Z Vargay; G Simon; M Winter; T Szüts
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

3.  Toxicity assessment of papaverine hydrochloride and papaverine-derived metabolites in primary cultures of rat hepatocytes.

Authors:  J C Davila; C G Reddy; P J Davis; D Acosta
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

4.  The fate of drotaverine-acephyllinate in rat and man. II. Human pharmacokinetics of drotaverine-14C-acephyllinate.

Authors:  Z Vargay; T Deutsch; I Szatmári; T Szüts; P Várkonyi; S Kerpel-Fronius; S Eckhardt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.